Position in ERAS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$223,221,047
+$72,745,688 QoQ
Shares Held
12,184,555
+31.0% QoQ
Ownership
3.48%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. ERAS ranks #41 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in ERAS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $223,221,047 | 12,184,555 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $150,475,359 | 9,300,084 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,969,668 | 6,174,642 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,783,778 | 4,029,256 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,082,679 | 4,002,110 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,723,702 | 4,177,885 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $16,589,797 | 6,609,481 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,455,402 | 6,027,620 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,801,304 | 2,458,180 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,441,611 | 1,670,685 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,547,097 | 1,665,304 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,945,278 | 1,495,065 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,112,077 | 1,489,883 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,820,204 | 1,269,171 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $16,768,257 | 3,890,547 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $16,010,007 | 2,052,565 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $5,361,013 | 962,480 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,733,713 | 899,269 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,708,215 | 366,381 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,502,006 | 259,284 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||